This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Montgomery, S. A. Articles by Thompson, C. Search for Related Content PubMed Articles by Montgomery, S. A. Articles by Thompson, C. Social Bookmarking                         What's this?

Guidelines for treating depressive illness with antidepressants

A statement from the British Association for Psychopharmacology

P. Bebbington

P. Cowen

W. Deakin

P. Freeling

C. Hallstrom

C. Katona

D. King

B. Leonard

S. Levine

A. Phanjoo

M. Peet

C. Thompson

Depression is a common illness which affects some 3% of the population per year. At least 25% of those with marked depression do not consult their general practitioner and in half of those who do the illness is not detected. Depression is easy to recognize when four or five of the core symptoms have been present for 2 weeks which often coincides with some occupational and social impairment. The core symptoms are depressed mood, loss of interest or pleasure, loss of energy or fatigue, concentration difficulties, appetite disturbance, sleep disturbance, agitation or retardation, worthlessness or self blame and suicidal thoughts. A diagnosis of depression is made when five of these core symptoms, one of which should be depressed mood or loss of interest or pleasure, have been present for 2 weeks. Four core symptoms are probably sufficient. Response to antidepressants is good in those with more than mild symptoms. When there are only few or very mild depressive symptoms evidence of response to antidepressants is more uncertain. Antidepressants are effective, they are not addictive and do not lose efficacy with prolonged use. The newer antidepressants have fewer side effects than the older tricyclics, they are better tolerated and lead to less withdrawals from treatment. They are less cardiotoxic and are safer in overdose. Antidepressants should be used at full therapeutic doses. Treatment failure is often due to too low a dose being used in general practice. It may be difficult to reach the right dose with the older tricyclics because of side effects. To consolidate response, treatment should be continued for at least 4 months after the patient is apparently well. Stopping the treatment before this is ill-advised as the partially treated depression frequently returns. Most depression is recurrent. Long-term antidepressant treatment is effective in reducing the risk of new episodes of depression and should be continued to keep the patient well.

Key Words: antidepressants • depressive illness • treatment • guidelines

Journal of Psychopharmacology, Vol. 7, No. 1 suppl, 19-23 (1993)
DOI: 10.1177/0269881193007001041


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. Burns and J. O'Brien Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology J Psychopharmacol, November 1, 2006; 20(6): 732 - 755. [Abstract] [PDF]

				A. R. Lingford-Hughes, S. Welch, and D. J. Nutt Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology J Psychopharmacol, September 1, 2004; 18(3): 293 - 335. [PDF]

				I. M. Anderson, D. J. Nutt, and J. F. W. Deakin Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines J Psychopharmacol, January 1, 2000; 14(1): 3 - 20. [Abstract] [PDF]

				R. L. Dunn, J. M. Donoghue, R. J. Ozminkowski, D. Stephenson, and T. R. Hylan Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines J Psychopharmacol, March 1, 1999; 13(2): 136 - 143. [Abstract] [PDF]

				R. Lane The long-term management of depression J Psychopharmacol, January 1, 1995; 9(2_suppl): 191 - 198. [Abstract] [PDF]

				T. Dinan Treatment approaches to therapy-resistant depression J Psychopharmacol, January 1, 1995; 9(2_suppl): 199 - 204. [Abstract] [PDF]